Please complete the form below if you do not wish to receive product information about Onglyza (saxagliptin) and related disease education information.

When you are finished, click "Unsubscribe."

If you would prefer to phone in your request, please contact Bristol-Myers Squibb at
1-877-920-1901, Monday through Friday 8:00 AM – 8:00 PM ET, excluding holidays.

Contact Information
*Indicates required fields

Bristol-Myers Squibb and AstraZeneca respect the privacy of visitors to this Web site. Please see our privacy statement for more information.

  • Preferences

    Please select the options for which you wish to discontinue receiving information. The last option will discontinue all communications.

    for ONGLYZA (saxagliptin)

    Do not take ONGLYZA (saxagliptin) if you are allergic to any of its ingredients. Serious allergic reactions can occur with ONGLYZA and may include swelling of the face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives, rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA and contact your doctor right away.

    Serious side effects can happen to people taking ONGLYZA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking ONGLYZA, tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism, or high triglyceride levels. Stop taking ONGLYZA and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.


    ONGLYZA (saxagliptin) is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

    ONGLYZA should not be used to treat people with type 1 diabetes or diabetic ketoacidosis (increased ketones in the blood or urine).

    If you have had inflammation of the pancreas (pancreatitis), it is not known if you have a higher chance of getting pancreatitis while taking ONGLYZA.

    When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

    When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

    The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

    Your doctor should test your blood to measure how well your kidneys are working before and during treatment with ONGLYZA. You may need a lower dose if your kidneys are not working well.

    Tell your doctor if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your doctor may need to change your dose of ONGLYZA.

    Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant or breast-feed.

    You are encouraged to report negative side effects of prescription drugs to the FDA.
    Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

    Please click here for Medication Guide, and click here for US Full Prescribing Information for ONGLYZA (saxagliptin).

    This product information is intended for US customers only.

    ©2013 AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company.

    ONGLYZA® is a trademark of Bristol-Myers Squibb Company.

    422US13BR01333-01-01 06/13

    US Full Prescribing Information   Medication Guide  Unsubscribe  Privacy Statement  Legal Notice   Site Map

    BMS Logo AstraZeneca Logo

    Bristol-Myers Squibb Patient Assistance Foundation:
    This non-profit organization provides assistance to
    qualifying patients with financial hardship who generally
    have no prescription insurance. Contact 1-800-736-0003
    or visit www.bmspaf.org for more information.